New Study Offers Hope for More Effective Treatment of Leukemia

Hepatitis B and C linked to risk of Parkinson’s disease
April 17, 2017
Multiple sclerosis: Novel immunotherapy reverses paralysis in mice
April 17, 2017
Show all

New Study Offers Hope for More Effective Treatment of Leukemia

Scientists are finding more ways to predict who will develop cancer.

The discovery of a protein signature that is highly predictive of leukemia could lead to novel treatments of the leading childhood cancer, according to new study showing that competition among certain proteins causes an imbalance that leads to leukemia.

The new study in the journal Nature Immunology reveals that the activation of a protein known as STAT5 causes competition among other proteins that leads to acute lymphoblastic leukemia (ALL). If a drug could be developed to prevent the initial activation of STAT5 and restore the natural balance of proteins, ALL could potentially be treated more effectively.

Blood cancers account for nearly 10 percent of all newly diagnosed cancer cases in the United States. Childhood acute lymphoblastic leukemia – a type of cancer in which the bone marrow produces too many immature lymphocytes (a type of white blood cell) – accounts for three out of every four cases of leukemia and is the most common in children under age five.

Read full article: New Study Offers Hope for More Effective Treatment of Leukemia

Read Full Article: New Study Offers Hope for More Effective Treatment of Leukemia

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.